Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: Who, When, and How?

Although the majority of patients with acute myeloid leukemia (AML) treated with intensive chemotherapy achieve a complete remission (CR), many are destined to relapse if treated with intensive chemotherapy alone. Allogeneic stem cell transplant (allo-SCT) represents a pivotally important treatment...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Justin Loke, Richard Buka, Charles Craddock
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2021-05-01
Edice:	Frontiers in Immunology
Témata:	acute myeloid leukemia allogeneic stem cell transplantation graft-versus-leukemia chemotherapy minimal residual disease measurable residual disease (MRD)
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.659595/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!